A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 98,300 shares of AMPH stock, worth $3.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,300
Previous 106,100 7.35%
Holding current value
$3.72 Million
Previous $4.24 Million 12.39%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $288,522 - $390,702
-7,800 Reduced 7.35%
98,300 $4.77 Million
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $765,270 - $860,903
-19,800 Reduced 15.73%
106,100 $4.24 Million
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $64,275 - $95,175
-1,500 Reduced 1.18%
125,900 $5.53 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $1.87 Million - $2.64 Million
42,000 Added 49.18%
127,400 $7.88 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $582,528 - $832,000
12,800 Added 17.63%
85,400 $3.93 Million
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $482,895 - $788,130
13,500 Added 22.84%
72,600 $4.17 Million
Q1 2023

May 15, 2023

SELL
$27.99 - $37.92 $596,187 - $807,696
-21,300 Reduced 26.49%
59,100 $2.22 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $284,886 - $318,954
-10,200 Reduced 11.26%
80,400 $2.25 Million
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $573,248 - $785,200
-20,800 Reduced 18.67%
90,600 $2.55 Million
Q2 2022

Aug 15, 2022

BUY
$29.79 - $42.29 $2.61 Million - $3.71 Million
87,700 Added 370.04%
111,400 $3.88 Million
Q1 2022

May 16, 2022

BUY
$22.96 - $36.45 $142,352 - $225,990
6,200 Added 35.43%
23,700 $851,000
Q4 2021

Feb 14, 2022

BUY
$18.14 - $23.29 $16,326 - $20,961
900 Added 5.42%
17,500 $408,000
Q3 2021

Nov 15, 2021

SELL
$17.83 - $21.49 $14,263 - $17,192
-800 Reduced 4.6%
16,600 $316,000
Q2 2021

Aug 16, 2021

SELL
$17.11 - $20.92 $362,732 - $443,504
-21,200 Reduced 54.92%
17,400 $351,000
Q1 2021

May 17, 2021

SELL
$17.21 - $20.65 $49,909 - $59,884
-2,900 Reduced 6.99%
38,600 $707,000
Q4 2020

Feb 16, 2021

SELL
$17.76 - $21.24 $2.05 Million - $2.46 Million
-115,600 Reduced 73.58%
41,500 $835,000
Q3 2020

Nov 16, 2020

BUY
$17.99 - $22.22 $2.83 Million - $3.49 Million
157,100 New
157,100 $2.95 Million
Q4 2019

Feb 14, 2020

SELL
$17.07 - $20.64 $380,661 - $460,272
-22,300 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$19.12 - $22.62 $240,912 - $285,012
-12,600 Reduced 36.1%
22,300 $442,000
Q2 2019

Aug 14, 2019

BUY
$18.92 - $22.96 $192,984 - $234,192
10,200 Added 41.3%
34,900 $737,000
Q1 2019

May 15, 2019

BUY
$19.46 - $25.28 $212,114 - $275,552
10,900 Added 78.99%
24,700 $505,000
Q4 2018

Feb 14, 2019

BUY
$17.72 - $22.51 $244,535 - $310,638
13,800 New
13,800 $275,000
Q2 2018

Aug 14, 2018

SELL
$14.63 - $19.6 $178,486 - $239,120
-12,200 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$17.23 - $20.35 $210,206 - $248,270
12,200 New
12,200 $229,000
Q4 2017

Feb 14, 2018

SELL
$17.76 - $19.75 $182,928 - $203,425
-10,300 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$14.73 - $17.99 $151,719 - $185,296
10,300
10,300 $184,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.85B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.